Sentence examples for but the current analysis from inspiring English sources

The epidemic is ongoing in Thailand in 2005, but the current analysis includes only outbreaks from January to December 2004.

We have assumed that vaccination offers lifetime protection, but the current analysis only requires protection for the next 18 years (i.e. up to 2025).

In earlier analyses of our study, bicycle-specific infrastructure was found to have lower injury crash risk than major streets without such infrastructure, 17 but the current analysis indicates that if a crash did occur, injury severity was similar.

Phylogenetic analysis of IFITMs in various vertebrates has been undertaken previously [ 12] but the current analysis has expanded the data, including all identified marsupial IFITMs and also amphibian IFITMs.

The NPHS longitudinal cohort included 17,276 participants, but the current analysis was restricted initially to n = 15,254 respondents who were over the age of 12 at the time of the initial 1994 baseline interview.

The clinical impact of this change is not yet known, but the current analysis suggests that it will substantially alter the population identified as having pre-diabetes with tens of millions of Americans who would have been considered to have pre-diabetes previously being classified as not having pre-diabetes.

The final coding and selection of participant quotes was verified by another qualitative researcher involved with the larger study but not the current analysis (SM).

The country was then represented by a single regional cancer registry comprising only 8% of the population, but in the current analysis, the new national cancer registry was used.

The study sample of the Ginerisk study included a total of 4,157 participants, but for the current analysis 1,375 participants were excluded as information on BMD, date of diagnosis of osteoporosis or on HRQoL were not available.

29 The results for the unadjusted network meta-analysis are consistent with those published previously, 30 but, in addition, the current analysis shows a statistically significant benefit of CRT-D over both ICD and CRT-P, with the differences driven by evidence from more recently published trials.

CATT and IVAN provide robust data to guide regulators in this decision, demonstrating that ranibizumab and bevacizumab have comparable effects on vision and similar safety profiles, 5 7 but that (based on the current analysis of IVAN) ranibizumab costs £3.5 million per QALY compared with bevacizumab.